Literature DB >> 15604456

Sequence-dependent cytotoxicity of second-generation oligonucleotides.

Denis Drygin1, Stephen Barone, C Frank Bennett.   

Abstract

In this study, we have examined the potential of second-generation antisense chimeric 2'-O-(2-methoxy)ethyl/DNA phosphorothioate oligonucleotides (ONs) to affect cell growth through non-antisense mechanisms. Evaluation of a series of ONs demonstrated that only a small number were cytotoxic at concentrations close to those required for antisense activity. Toxicity of the ONs appeared to be sequence dependent and could be affected by base and backbone modifications. Caspase-3 activation occurs with some ONs and it is most likely secondary to necrosis rather than apoptosis, since cells treated with toxic ONs did not show chromatin condensation, but did exhibit high-extracellular lactate dehydrogenase activity. Caspase-3 activation does not correlate with and appears not to be required for the inhibition of cell proliferation. Toxicity was only observed when ONs were delivered intracellularly. The mechanism by which one of the most cytotoxic ON produces cytotoxicity was investigated in more detail. Treatment with the cytotoxic ON caused disruption of lysosomes and Pepstatin A, a specific inhibitor of aspartic proteases, reduced the cytotoxicity of the ON. Reduction of lysosomal aspartic protease cathepsin D by prior treatment with cathepsin D-specific antisense ON did not attenuate the cytotoxicity, suggesting that other aspartic proteases play a crucial role in the cellular proliferation inhibition by ONs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604456      PMCID: PMC545465          DOI: 10.1093/nar/gkh997

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non-antisense, p53-mediated mechanism.

Authors:  Laura Papucci; Nicola Schiavone; Martino Donnini; Andrea Lapucci; Ettore Luzi; Alessio Tempestini; Ewa Witort; Sergio Capaccioli
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2002-02

3.  Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals.

Authors:  Alam Nur-E-Kamal; Tsai-Kun Li; Ailing Zhang; Haiyan Qi; Eszter S Hars; Leroy F Liu
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

4.  Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.

Authors:  R A McKay; L J Miraglia; L L Cummins; S R Owens; H Sasmor; N M Dean
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

5.  Chemically modified oligonucleotides exhibit decreased immune stimulation in mice.

Authors:  S Henry; K Stecker; D Brooks; D Monteith; B Conklin; C F Bennett
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

6.  Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice.

Authors:  Madeline Butler; Robert A McKay; Ian J Popoff; William A Gaarde; Donna Witchell; Susan F Murray; Nicholas M Dean; Sanjay Bhanot; Brett P Monia
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

7.  Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.

Authors:  R S Geary; T A Watanabe; L Truong; S Freier; E A Lesnik; N B Sioufi; H Sasmor; M Manoharan; A A Levin
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

8.  Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis.

Authors:  Nicolas Bidère; Hans K Lorenzo; Sylvie Carmona; Mireille Laforge; Francis Harper; Céline Dumont; Anna Senik
Journal:  J Biol Chem       Date:  2003-06-02       Impact factor: 5.157

9.  Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines.

Authors:  Gaochao Tian; Cynthia D Sobotka-Briner; John Zysk; Xiaodong Liu; Cynthia Birr; Mark A Sylvester; Philip D Edwards; Clay D Scott; Barry D Greenberg
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

10.  Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.

Authors:  Timothy A Vickers; Seongjoon Koo; C Frank Bennett; Stanley T Crooke; Nicholas M Dean; Brenda F Baker
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

View more
  8 in total

1.  Antisense oligonucleotide therapy for neurodegenerative disease.

Authors:  Richard A Smith; Timothy M Miller; Koji Yamanaka; Brett P Monia; Thomas P Condon; Gene Hung; Christian S Lobsiger; Chris M Ward; Melissa McAlonis-Downes; Hongbing Wei; Ed V Wancewicz; C Frank Bennett; Don W Cleveland
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

2.  Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence Features.

Authors:  Peter H Hagedorn; Jeffrey M Brown; Amy Easton; Maria Pierdomenico; Kelli Jones; Richard E Olson; Stephen E Mercer; Dong Li; James Loy; Anja M Høg; Marianne L Jensen; Martin Gill; Angela M Cacace
Journal:  Nucleic Acid Ther       Date:  2022-02-14       Impact factor: 4.244

3.  Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs.

Authors:  Charlotte Andrieu-Soler; Mariana Casas; Anne-Marie Faussat; Christelle Gandolphe; Marc Doat; Denis Tempé; Carine Giovannangeli; Francine Behar-Cohen; Jean-Paul Concordet
Journal:  Nucleic Acids Res       Date:  2005-07-07       Impact factor: 16.971

4.  Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.

Authors:  Eric E Swayze; Andrew M Siwkowski; Edward V Wancewicz; Michael T Migawa; Tadeusz K Wyrzykiewicz; Gene Hung; Brett P Monia; C Frank Bennett
Journal:  Nucleic Acids Res       Date:  2006-12-19       Impact factor: 16.971

Review 5.  A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics.

Authors:  Kirsten Deprey; Nefeli Batistatou; Joshua A Kritzer
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

6.  Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice.

Authors:  Karah Nazor Friberg; Gene Hung; Ed Wancewicz; Kurt Giles; Chris Black; Sue Freier; Frank Bennett; Stephen J Dearmond; Yevgeniy Freyman; Pierre Lessard; Sina Ghaemmaghami; Stanley B Prusiner
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-07       Impact factor: 10.183

7.  Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs.

Authors:  Sabine Sewing; Franziska Boess; Annie Moisan; Cristina Bertinetti-Lapatki; Tanja Minz; Maj Hedtjaern; Yann Tessier; Franz Schuler; Thomas Singer; Adrian B Roth
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

8.  Carrier-free Gene Silencing by Amphiphilic Nucleic Acid Conjugates in Differentiated Intestinal Cells.

Authors:  Elena Moroz; Soo Hyeon Lee; Ken Yamada; François Halloy; Saúl Martínez-Montero; Hartmut Jahns; Jonathan Hall; Masad J Damha; Bastien Castagner; Jean-Christophe Leroux
Journal:  Mol Ther Nucleic Acids       Date:  2016-09-20       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.